Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Tetra Bio-Pharma Inc., CA88166Y1007

Tetra Bio-Pharma Inc., CA88166Y1007

14.10.2021 - 14:42:11

Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF

14.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Tetra Bio-Pharma Inc. Ottawa

Canada Internet: https://tetrabiopharma.com/ ISIN: CA88166Y1007 WKN: A2ASQ8 EQS News ID: 1240853 ? End of News DGAP News Service

1240853??14.10.2021?

@ dgap.de